MBX Biosciences Inc [MBX] stock is trading at $20.97, up 5.75%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The MBX shares have gain 29.13% over the last week, with a monthly amount drifted -4.07%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
MBX Biosciences Inc [NASDAQ: MBX] stock has seen the most recent analyst activity on October 08, 2024, when Stifel initiated its Buy rating and assigned the stock a price target of $40. Previously, JP Morgan started tracking the stock with Overweight rating on October 08, 2024, and set its price target to $30. On October 08, 2024, Jefferies initiated with a Buy rating and assigned a price target of $35 on the stock. Guggenheim started tracking the stock assigning a Buy rating and suggested a price target of $44 on October 08, 2024.
MBX Biosciences Inc [MBX] stock has fluctuated between $15.31 and $27.50 over the past year. Currently, Wall Street analysts expect the stock to reach $44 within the next 12 months. MBX Biosciences Inc [NASDAQ: MBX] shares were valued at $20.97 at the most recent close of the market. An investor can expect a potential return of 109.82% based on the average MBX price forecast.
Analyzing the MBX fundamentals
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 19.78 points at the first support level, and at 18.59 for the second support level. However, for the 1st resistance point, the stock is sitting at 22.38, and for the 2nd resistance point, it is at 23.79.
Ratios To Look Out For
For context, MBX Biosciences Inc’s Current Ratio is 25.75. Also, the Quick Ratio is 25.75.
Transactions by insiders
Recent insider trading involved Mathers Edward T, Director, that happened on Sep 16 ’24 when 0.5 million shares were purchased. 10% Owner, BASKETT FOREST completed a deal on Sep 16 ’24 to buy 0.5 million shares. Meanwhile, 10% Owner Behbahani Ali bought 0.5 million shares on Sep 16 ’24.
